IMMU-114 is antibody-drug conjugate consisting of humanized anti-HLA-DR IgG4 monoclonal antibody specific for alpha-chain linked to SN-38 via a CL2A linker.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.